Rollins gift to establish urgent care center for Winship cancer patients

Funded by a multi-million dollar gift from The Ma-Ran Foundation, Winship will establish an immediate care facility to bridge the gap between cancer centers and emergency rooms. The Rollins Immediate Care Center of Winship at Emory University Hospital is expected to open in spring 2022. Pictured: The center is being designed via a collaborative process involving a multi-disciplinary team of patients, nurses, physicians, and research staff.

NCI R01 advances research in collective lung cancer cell invasion

Drs. Mala Shanmugam and Adam Marcus are multi-PIs on a new R01 grant from the National Cancer Institute for their project, “Implications of metabolic heterogeneity on collective lung cancer cell invasion.” This work will contribute to the understanding of lung cancer metastasis and further develop new treatments that target invading cancer cells.

View in NIH RePORTER

Rally Foundation grants support new pediatric cancer research

Drs. Andrew Hong, Katharine Brock, and Muxiang Zhou have been awarded grants from the Rally Foundation for Childhood Cancer Research. The grants will support the development of in vitro models of Wilms tumors (Hong), a telehealth hospice transition intervention (Brock), and novel MYCN inhibitors for pediatric neuroblastoma therapies (Zhou).

Correll Family Foundation gift honors Ritenour

The Correll Family Foundation has established the Correll Distinguished Clinician Leadership Fund in honor of Chad Ritenour, MD, for his leadership responsibilities within Emory Healthcare. Through the foundation, the Correll family has funded chairs, scholarships, and professorships.

View Profile

Medical physicists receive DABR certification

Drs. Matthew Walb, Tonghe Wang, and Zhen Tian completed certification in medical physics and are now Diplomates of the American Board of Radiology (DABR). The comprehensive certification process involves educational requirements, peer evaluation, and examination.

About ABR Certification

The 12th annual Winship Oncology Nursing Symposium, “Getting our Groove Back: Bringing Oncology Nursing to the Forefront,” will be held virtually on June 12. Registration is free for Emory employees. Up to 20 continuing education credits can be earned live or on-demand after the conference.

Emory’s Nell Hodgson Woodruff School of Nursing will host the second annual Summer Institute on Symptoms and Omics as a virtual event, May 13-14. Speakers include Winship members Drs. Dean Jones, Mi-Kyung Song, and Jessica Wells, and other researchers in the fields of metabolomics and symptom science.

What's new in the Emory Integrated Genomics Core

The Emory Integrated Genomics Core, one of Winship’s 11 shared resources offering advanced research technologies and services, provides leading-edge genomics platforms and expertise. The Covaris E220, a DNA/RNA/chromatin shearing instrument and one of the core's newer platforms, uses ultrasonic pulses to uniformly shear nucleic acids and generate appropriately-sized nucleic acid preps for various protocols. Contact the Emory Integrated Genomics Core (eigc@emory.edu) to learn more about this and other technologies and services to support your research.

Learn More

Below are three selected Winship publications out of 17 published over the past week:

Shah BD, Bishop MR, Oluwole OO, Logan AC, Baer MR, Donnellan WB, O'Dwyer KM, Holmes H, Arellano ML, Ghobadi A, Pagel JM, Lin Y, Cassaday RD, Park J, Abedi M, Castro J, DeAngelo DJ, Malone AK, Mawad R, Schiller G, Rossi JM, Bot A, Shen T, Goyal L, Jain RK, Vezan R, Wierda WG. KTE-X19 anti-CD19 CAR T-cell therapy in adult relapsed/refractory acute lymphoblastic leukemia: ZUMA-3 phase 1 results. Blood. 2021; PubMed PMID: 33827116.

View in PubMed

Woolpert KM, Ward KC, England CV, Lash TL. Validation of LexisNexis Accurint in the Georgia Cancer Registry's Cancer Recurrence and Information Surveillance Program. Epidemiology (Cambridge, Mass.). 2021; 32(3):434-438. PubMed PMID: 33591053; PubMed Central PMCID: PMC8012233.

View in PubMed

Broman KK, Hughes T, Dossett L, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma JM, Deneve JL, Fleming MD, Perez MC, Lowe MC, Olofsson Bagge R, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley G, Hui JYC, Been L, Kruijff S, Kim Y, Naqvi SMH, Sarnaik AA, Sondak VK, Zager JS. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT-2). Cancer. 2021; PubMed PMID: 33826754.

View in PubMed